Zayads Lifesains announced on Wednesday that the company is set to launch the Quadrivet influenza virus vaccine in India for use in the Southern Hemisphere of 2025. This vaccine will be the first flu security vaccine of this season in India.
According to the company, this vaccine from A/Victoria/4897/2022 (H1N1) PDM09- Like virus, A/Croatia/10136RV/2023 (H3N2)-like virus, b/austria/1359417/2021 (B/Victoria Lineage)-B/Victoria Lineage) (B/Yamagata Lineage)-Like virus will get protection. Now we will know what benefits people will get from the arrival of this vaccine.
Detailed security: Vaxiflu-4 is a quadrivet vaccine, providing protection from four major stress (H1N1, H3N2, B/Victoria, and B/Yamagata) of the flu. This will provide extensive security against the flu.
Low risk vaccination: This vaccine reduces the risk of vaccination, as it protects against problems caused by wrong stress and works on the right stress.
Defense against seasonal flu: Vaxiflu-4 vaccination can prevent the outbreak of flu outbreak every year, causing serious consequences of flu, such as hospitalization and death risk.
Security for children, elderly and weak immunity: This vaccination is very important for high -risk groups (such as young children, old people and weak immunity), for which flu can cause serious problems.
Contribution to health safety: The Vaxiflu-4 vaccine will be brought to the market, which is a division of the company. The vaccine has been developed at Ahmedabad -based Vacancation Technology Center (VTC), which is capable of research, development and construction of safe and effective vaccines.
Dr. Sharavil Patel, Managing Director, Zayads LifeSyinses Limited said, “The importance of preventable healthcare is increasing worldwide. In India, there is a need for inexpensive and high quality vaccines that can solve health problems. Through vaccines like Vaxiflu-4, we are contributing to the field of public health and is vaccinating annually to prevent the outbreak of the flu. ” According to the World Health Organization (WHO), seasonal flu causes 2,90,000 to 6,50,000 deaths every year.